Johnson & Johnson (JNJ) beat first-quarter expectations, as growth in the health care giant's home market helped counter another revenue hit overseas from a strong dollar.

The health care giant booked a $68 million loss on a one-time charge in the quarter, and revenue grew more than 5% to $24.75 billion.

Adjusted earnings totaled $2.68 per share.

FactSet says analysts forecast earnings of $2.50 per share on $23.6 billion in revenue.

The New Brunswick, New Jersey, company on Tuesday boosted the lower end of its forecasted range for 2023 adjusted earnings by a dime. It now expects between $10.50 and $10.60 per share.

Analysts expect earnings of $10.51 per share this year. Shares climbed 1.67% in early morning trading.